Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · IEX Real-Time Price · USD
1.05
-0.02 (-1.87%)
At close: Dec 29, 2023, 4:00 PM
1.08
+0.03 (2.86%)
After-hours: Dec 29, 2023, 7:57 PM EST
Aclaris Therapeutics Stock Forecast
ACRS's stock price has decreased by -93.49% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 5 stock analysts, the average 12-month stock price forecast for ACRS stock stock is $16.4, which predicts an increase of 1,461.90%. The lowest target is $1.00 and the highest is $29. On average, analysts rate ACRS stock stock as a buy.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ACRS stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 1 | 1 | 1 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +757.14% | Dec 29, 2023 |
| Stifel | Stifel | Hold Maintains $2 → $1 | Hold | Maintains | $2 → $1 | -4.76% | Dec 18, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $43 → $9 | Strong Buy | Maintains | $43 → $9 | +757.14% | Nov 14, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 14, 2023 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $20 → $2 | Strong Buy → Hold | Downgrades | $20 → $2 | +90.48% | Nov 13, 2023 |
Financial Forecast
Revenue This Year
18.06M
from 29.75M
Decreased by -39.31%
Revenue Next Year
11.78M
from 18.06M
Decreased by -34.75%
EPS This Year
-1.68
from -1.33
EPS Next Year
-1.37
from -1.68
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 24.5M | 39.0M | 42.8M | 47.1M | 51.9M | 122.9M |
| Avg | 18.1M | 11.8M | 12.9M | 15.2M | 21.3M | 55.8M |
| Low | 14.1M | 2.8M | 2.8M | 2.8M | 6.8M | 6.9M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -17.7% | 115.7% | 263.6% | 265.5% | 240.8% | 477.6% |
| Avg | -39.3% | -34.8% | 9.5% | 18.0% | 39.7% | 162.3% |
| Low | -52.6% | -84.7% | -76.5% | -78.6% | -55.6% | -67.7% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -1.63 | -0.90 | -0.92 | -0.68 | -0.62 | -0.60 |
| Avg | -1.68 | -1.37 | -1.39 | -1.68 | -1.59 | -1.47 |
| Low | -1.72 | -2.09 | -3.12 | -3.11 | -3.11 | -2.95 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | - |
| Avg | - | - | - | - | - | - |
| Low | - | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.